D. Eric Mendelsohn has been the CEO and President of National Health Investors (NHI) since October 2015, following a quick rise within the company after joining as Executive VP of Corporate Finance in early 2015. He has over 15 years...

D. Eric Mendelsohn has been the CEO and President of National Health Investors (NHI) since October 2015, following a quick rise within the company after joining as Executive VP of Corporate Finance in early 2015. He has over 15 years of experience in healthcare real estate and finance, a field he's navigated since working at Emeritus Senior Living, where his role involved handling financing and acquisitions for assisted living properties. Mendelsohn holds degrees in International Relations, Law, and Banking and Finance, giving him a solid foundation in both legal and financial realms. Under his leadership, NHI has focused on strategic investments and has established an effective stock buyback plan. His compensation reflects the challenges faced by the healthcare industry; he earned $1.4 million in 2023, with a significant portion being a discretionary bonus due to his dedication through tough times like the COVID-19 pandemic. His direct involvement in both the executive and board functions of NHI showcases his commitment to aligning company goals with investor interests.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other National Health Investors CEOs

N

D. Eric Mendelsohn

CEO of National Health Investors

Education

Bachelor of Science from American University, Law Degree from Pepperdine University, Masters (LLM) in Banking and Finance from Boston University

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Real Estate

CEO of National Health Investors for

9 years 10 months (Oct 2015 - Present)

Previous Experience

Senior Vice President of Corporate Development at Emeritus Senior Living

Rivals

Competitors/colleagues of D. Eric Mendelsohn

F

William H. Lenehan

CEO of Four Corners Property Trust

2023 Compensation

Stock

$167.50K

Salary

$670.00K

Bonus

$837.50K

Other

$254.28K

Total Holdings

$32.32M

V

Debra A. Cafaro

CEO of Ventas

2023 Compensation

Stock

$150.00K

Salary

$900.00K

Bonus

$300.00K

Other

$50.00K

Total Holdings

$161.54M

V

Peter J. Bulgarelli

CEO of Ventas

2023 Compensation

Stock

$150.00K

Salary

$950.00K

Bonus

$300.00K

Other

$100.00K

Total Holdings

$16.79M

S

Richard K. Matros

CEO of Sabra Healthcare

2023 Compensation

Stock

$4.34M

Salary

$925.00K

Bonus

$2.78M

Other

$0.00

Total Holdings

$11.98M

Holdings

See how much did D. Eric Mendelsohn make over time.

Eric Mendelsohn, as of 2023, holds approximately 379,586 shares of National Health Investors (NHI). This positions him as a significant stakeholder, reflecting his strong personal investment in the company. His holdings became notably substantial as he joined the executive team...

Eric Mendelsohn, as of 2023, holds approximately 379,586 shares of National Health Investors (NHI). This positions him as a significant stakeholder, reflecting his strong personal investment in the company. His holdings became notably substantial as he joined the executive team in early 2015, and he has continued to increase his ownership through stock incentives. While he faced ups and downs like many in the industry, Mendelsohn's commitment to NHI is clear in the way his financial portfolio aligns with the company’s long-term objectives. His largest wealth leap came when he was granted stock options in previous years, which tied directly to NHI’s performance and growth. However, in the face of challenges, including the pandemic, Mendelsohn maintained a substantial investment in the company to emphasize his confidence in its recovery and ongoing strategy.

Loading...

Total Stock Sold

$362.16K

NHI

$362.16K

4,000 NHI shares

What if they kept their stock?

If D. Eric Mendelsohn didn't sell their stock, today they would have:
Extra NHI4,000 shares worth $251.48K.
This is -30.56% and $110.68K less than what they got when they sold the stock.

Insider Trading

See recent insider trades of D. Eric Mendelsohn.

NHI

3,000 shares

NHI

Feb 23, 2024

Received

NHI

5,000 shares

NHI

May 5, 2023

Received

NHI

$108.78K

NHI at $54.39/share

Sep 29, 2021

Purchase

NHI

$120.55K

NHI at $60.27/share

Mar 12, 2020

Purchase

NHI

$362.33K

NHI at $90.58/share

Feb 21, 2020

Sale

NHI

$130.95K

NHI at $65.48/share

Feb 22, 2018

Purchase

NHI

$56.12K

NHI at $56.12/share

Nov 17, 2015

Purchase

NHI

$41.54K

NHI at $55.38/share

Aug 26, 2015

Purchase

NHI

$42.74K

NHI at $56.99/share

Aug 24, 2015

Purchase

NHI

$88.20K

NHI at $58.80/share

Aug 13, 2015

Purchase

Compensation History

See how much did D. Eric Mendelsohn make over time.

In 2023, Eric Mendelsohn's total compensation was around $1,419,444, which included a salary of $500,000 and a hefty bonus of $875,000 directly tied to his performance in navigating the complexities of the healthcare sector. His bonus was largely thanks to achieving key objectives under the company's incentive plan. He also received value from 5,000 shares of restricted stock. The structured compensation plan is designed to motivate executive performance while aligning with NHI's overall goals and investor returns. Over the years, his compensation has reflected the challenges of the healthcare environment; despite missing criteria in past plans, he has adapted his strategy to ensure successful leadership during crises like COVID-19, earning considerable discretionary bonuses for his adaptability and foresight.

Year

2023

Total Compensation

$1.63M

Salary

$500.00K

Board Justification

The compensation philosophy is designed to align executive compensation with company performance and investor returns, focusing on motivating and retaining qualified senior officers.

Bonus

$875.04K

Board Justification

The bonus was based on the 2023 Incentive Plan performance goals, which were linked to company performance and investor returns.

Other

$9.90K

Board Justification

Represents employer contributions to NHI’s 401(k) Plan.

Restricted Stock

$246.50K(5K restricted stock)

Board Justification

5,000 shares of restricted stock were granted on May 5, 2023, vesting over five years with 20% vesting on each of the first five anniversaries of the date of grant.

Performance Metrics

The performance metrics include Normalized FAD increases, Normalized FAD payout ratio, new investment yield, SHOP revenue increases, and deferral collections.

Other National Health Investors CEOs

Here are other CEOs of National Health Investors

Justin Hutchens

Ex-CEO of National Health Investors

February 2009 - August 2015